Press Enter to search · ESC to close

Macro

China Adds JW Therapeutics’ CAR-T Drug Relma-cel to National Reimbursement List

China’s National Healthcare Security Administration said on November 14 that JW Therapeutics’ CAR-T therapy relma-cel has been added to the national reimbursement drug list. Before inclusion, relma-cel was priced at 1.29 million yuan per infusion. Ma Jun, director of the Harbin Institute of Hematology and Oncology, said the price has now dropped to below 300,000 yuan per infusion.

Share

Related News

新云社 share card
Long-press image above → Save to Photos / Share
Pitch us Feedback